Latest filing published 18 Dec 2017 for G1 Therapeutics, Inc., €3.4M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +13.3%Entry US$24.08 · Close at T+365 US$27.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
MedImmune Ventures, Inc.: trading record in brief
MedImmune Ventures, Inc. is a declared insider at 4 companies; the most frequent names are G1 Therapeutics, Inc., Astria Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. Between 1 April 2014 and 15 December 2017, the trades on record add up to 14 filings.
On the open market, the record shows 5 purchases worth €7.3M and 3 sales worth €9.0M. The net balance comes to €1.7M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2017 alone, the filings show 2 purchases and 3 sales.
The median purchase comes to €1.0M.
The newest entry dates from 18 December 2017: an open-market sale of €3.4M, in G1 Therapeutics, Inc. The latest purchase dates back some time: it was published 3,253 days ago, on 13 December 2017. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to MedImmune Ventures, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200,000 shares@ US$19.7530.5% of flowCommon Stock, $0.0001 par value per shareSEC:0000899243-17-029061:0
- 75,000 shares@ US$15.009.2% of flowCommon Stock, $0.0001 par value per shareSEC:0000899243-17-028595:0Canonical exit: 15 Aug 2017 (T+90)
- 133,906 shares@ US$19.7520.2% of flowCommon Stock, $0.0001 par value per shareSEC:0000899243-17-027927:0
- 200,000 shares@ US$20.0131.0% of flowCommon Stock, $0.0001 par value per shareSEC:0000899243-17-027243:0
- 75,000 shares@ US$15.009.1% of flowCommon StockSEC:0001209191-17-035151:1Canonical exit: 20 Aug 2017 (T+90)
- 3,409,536 sharesCommon StockSEC:0001209191-17-035151:0
- 1,079,115 sharesCommon StockSEC:0001104659-15-049012:0
- 330,098 sharesCommon StockSEC:0001104659-15-049012:1
- 223,439 shares@ US$12.00Common StockSEC:0001104659-15-049012:2Canonical exit: 28 Sept 2015 (T+90)
- 1,255,123 sharesCommon StockSEC:0001209191-15-018743:0
- 57,204 sharesCommon StockSEC:0001209191-15-018743:1
- 416,667 shares@ US$6.00Common StockSEC:0001209191-15-018743:2Canonical exit: 24 May 2015 (T+90)
- 1,376,461 sharesCommon StockSEC:0001209191-14-024136:0
- 75,735 shares@ US$12.00Common StockSEC:0001209191-14-024136:1Canonical exit: 30 Jun 2014 (T+90)
14 of 14 declarations
